Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Vulnerable patients with metastatic colorectal cancer in a real-world setting: A multicenter retrospective study.
Authors
Seiichiro Mitani
Kindai University Faculty of Medicine, Sayama-Shi, Japan;
Seiichiro Mitani , Yosuke Kito , Kaori Hino , Kentaro Kawakami , Naoki Izawa , Fumiyasu Hanamura , Yoshiyuki Yamamoto , Hirokazu Shoji , Azusa Komori , Shogen Boku , Kenji Tsuchihashi , Eishi Baba , Kyoko Kato , Yoshikane Nonagase , Toshihiko Matsumoto , Mitsuhiro Furuta , Hisato Kawakami
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 114)
DOI
10.1200/JCO.2023.41.4_suppl.114
Abstract #
114
Poster Bd #
F11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer.
First Author: Chengwei Peng
Poster
2020 ASCO Virtual Scientific Program
Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3).
First Author: Leonidas Apostolidis
Poster
2018 ASCO Annual Meeting
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab for patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction as second-line therapy – the RAMIRIS Study.
First Author: Sylvie Lorenzen
Poster
2018 ASCO Annual Meeting
Comparison of chemotherapy use, cost, and survival in patients with metastatic colorectal cancer in Western Washington and British Columbia.
First Author: Todd Yezefski